Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiomyocytes from human embryonic stem cells.

R Passier1, C Denning, C Mummery

  • 1Hubrecht Laboratory and Interuniversity Cardiology Institute of the Netherlands, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands.

Handbook of Experimental Pharmacology
|December 24, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence for intermittent coupling of intramyocardial small, engineered heart tissues acutely implanted into rabbit myocardium.

Cardiovascular research·2025
Same author

'Project period': a workplace health promotion innovation in a higher education setting.

Perspectives in public health·2023
Same author

Mixed-methods process evaluation of a residence-based SARS-CoV-2 testing participation pilot on a UK university campus during the COVID-19 pandemic.

BMC public health·2022
Same author

The changing vaccine landscape: rates of COVID-19 vaccine acceptance and hesitancy in young adults during vaccine rollout.

Perspectives in public health·2022
Same author

Modular operation of microfluidic chips for highly parallelized cell culture and liquid dosing via a fluidic circuit board.

Microsystems & nanoengineering·2021
Same author

Cell type-specific changes in transcriptomic profiles of endothelial cells, iPSC-derived neurons and astrocytes cultured on microfluidic chips.

Scientific reports·2021
Same journal

Endothelial Cell Phenotypic Plasticity in Atherosclerosis.

Handbook of experimental pharmacology·2026
Same journal

Endothelial Dysfunction and Neurovascular Alterations in Autism Spectrum Disorder.

Handbook of experimental pharmacology·2026
Same journal

Molecular Mechanisms of Endothelial Shear Stress Mechanotransduction in Health and Disease.

Handbook of experimental pharmacology·2026
Same journal

Microvasculature of the Pancreatic Islets of Langerhans in Health and Diabetes.

Handbook of experimental pharmacology·2026
Same journal

Mechanisms of Actions of Physiological, Pharmacological, and Toxicological Dietary Bioactive Inorganic Boron.

Handbook of experimental pharmacology·2026
Same journal

BNCT Plus Luminescence: New Paradigm for Boron-Containing Drug Design.

Handbook of experimental pharmacology·2026
See all related articles

Human embryonic stem cells (HESC) offer potential for replacing lost cardiac myocytes in heart failure. Research reviews HESC differentiation, properties, integration, and safety for cardiac cell transplantation therapies.

Area of Science:

  • Cardiology
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Terminal heart failure involves significant cardiac myocyte loss.
  • Stem cell therapy is a potential solution for myocyte replacement.
  • Identifying optimal stem cell sources for cardiac repair is ongoing.

Purpose of the Study:

  • To evaluate human embryonic stem cells (HESC) for cardiac cell transplantation.
  • To review HESC differentiation, properties, and integration into heart tissue.
  • To consider the safety of HESC for cardiac regenerative therapies.

Main Methods:

  • Review of methods for inducing HESC differentiation into cardiomyocytes.
  • Comparative analysis of HESC-derived cardiomyocytes and primary human cardiomyocytes.

Related Experiment Videos

  • Assessment of HESC integration into host myocardium.
  • Evaluation of general and cardiac-specific safety concerns for HESC transplantation.

    • Main Results:

    • Methods for HESC differentiation into cardiomyocytes are established.
    • HESC-derived cardiomyocytes exhibit specific properties relevant to cardiac function.
    • Potential for HESC integration into existing heart tissue exists.
    • Safety considerations for HESC cardiac transplantation require thorough investigation.

    Conclusions:

    • Human embryonic stem cells are a promising candidate for cardiac myocyte replacement therapy.
    • Further research is needed to optimize differentiation and ensure safety for clinical application.
    • HESC-based therapies hold potential for treating terminal heart failure.